New York State Common Retirement Fund’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-241,096
| Closed | -$11.2M | – | 3272 |
|
|
2019
Q2 | $11.2M | Sell |
241,096
-313,522
| -57% | -$8.8M | 0.01% | 922 |
|
|
2019
Q1 | $13.5M | Buy |
554,618
+127,098
| +30% | +$2.65M | 0.02% | 830 |
|
|
2018
Q4 | $6.09M | Buy |
427,520
+187,924
| +78% | +$2.85M | 0.01% | 1100 |
|
|
2018
Q3 | $3.64M | Sell |
239,596
-45,240
| -16% | -$693K | ﹤0.01% | 1405 |
|
|
2018
Q2 | $4.78M | Buy |
284,836
+24,220
| +9% | +$385K | 0.01% | 1282 |
|
|
2018
Q1 | $4.25M | Buy |
260,616
+40,814
| +19% | +$654K | 0.01% | 1287 |
|
|
2017
Q4 | $2.81M | Buy |
219,802
+744
| +0.3% | +$8.46K | ﹤0.01% | 1474 |
|
|
2017
Q3 | $2.69M | Buy |
219,058
+23,758
| +12% | +$221K | ﹤0.01% | 1479 |
|
|
2017
Q2 | $1.64M | Buy |
195,300
+11,699
| +6% | +$95.7K | ﹤0.01% | 1804 |
|
|
2017
Q1 | $1.64M | Buy |
183,601
+18,801
| +11% | +$200K | ﹤0.01% | 1780 |
|
|
2016
Q4 | $1.45M | Buy |
164,800
+31,400
| +24% | +$231K | ﹤0.01% | 1863 |
|
|
2016
Q3 | $900K | Hold |
133,400
| – | – | ﹤0.01% | 2049 |
|
|
2016
Q2 | $475K | Hold |
133,400
| – | – | ﹤0.01% | 2293 |
|
|
2016
Q1 | $394K | Hold |
133,400
| – | – | ﹤0.01% | 2343 |
|
|
2015
Q4 | $563K | Hold |
133,400
| – | – | ﹤0.01% | 2259 |
|
|
2015
Q3 | $608K | Sell |
133,400
-14,402
| -10% | -$85.4K | ﹤0.01% | 2222 |
|
|
2015
Q2 | $1.07M | Buy |
+147,802
| New | +$1.09M | ﹤0.01% | 2143 |
|
Other funds holding ARRY
New York State Common Retirement Fund's ARRY Position: Q3 2019 in Review
New York State Common Retirement Fund sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 241,096 shares — an estimated $11.2M sold.
New York State Common Retirement Fund first reported a position in ARRY in Q2 2015 and held it in 17 quarters. The position peaked at $13.5M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- New York State Common Retirement Fund reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- New York State Common Retirement Fund sold 241,096 Array Biopharma Inc shares in Q3 2019, an estimated $11.2M.
- New York State Common Retirement Fund first reported a position in Array Biopharma Inc in Q2 2015 and held it in 17 quarters.
- New York State Common Retirement Fund's Array Biopharma Inc position peaked at $13.5M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on New York State Common Retirement Fund's 13F filing for Q3 2019, filed 7 Nov 2019.